Last updated: 2026-09-16 12:18:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Lumexa Imaging Holdings, Inc. (LMRI) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $11.90, with a market capitalisation of $1.09B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.45 to $19.45. This page covers its latest market performance, valuation, price trends and company information.
$1.09B | |
$11.77 | |
$19.45 | |
$6.45 | |
$11.77 | |
11.00 | |
505.28K | |
-- | |
$19.45 | |
$6.45 | |
-- | |
-- |
Lumexa Imaging Holdings, Inc. (LMRI) is trading at $11.90 in pre-market trading as of 2026-09-16 12:00:00, up 1.14% ($0.13) from the previous close of $11.77
Pre-market trading shows how investors are pricing LMRI before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Lumexa Imaging Holdings, Inc. (LMRI) moved from $12.18 to $11.90, representing a decline of 2.27% ($0.28).
The stock traded between $11.10 and $12.32 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 308.86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 42.0%
LMRI is currently trading at $11.90, placing it 42.0% of the way from its 52-week low of $6.45 to its 52-week high of $19.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 4335 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lumexa Imaging Holdings, Inc. (LMRI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.